Tumblr Yahoos: Old ...
Health Care: Drugs
Palatin Technologies Inc. (PTN: AMEX)
$0.64 0.00 | 0.00%
05/20/13 - 03:59 PM ET
Company Cash Flow
| Jun 2012 | Jun 2011 | Jun 2010 | Jun 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -17.25M | -12.82M | -1.79M | -4.80M |
| Operating Gains/Losses | -442.25K | -113.68K | -95.00K | -550.97K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 103.52K | -128.27K | 505.65K | -502.78K |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -202.01K | 341.11K | -50.57K | -428.82K |
| (Decrease) Increase In Other Current Liabilities | 851.55K | -519.90K | 5.28M | -1.99M |
| (Increase) Decrease In Other Working Capital | -46.10K | 46.10K | 0.00 | 0.00 |
| Other Non-Cash Items | 892.30K | 758.86K | 968.56K | 1.48M |
| Net Cash From Continuing Operations | -15.49M | -11.03M | -5.73M | -5.44M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -15.49M | -11.03M | -5.73M | -5.44M |
| Sale of Property, Plant & Equipment | 494.38K | 5.30K | 45.00K | 700.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -15.00K | 0.00 | -7.00K | -36.38K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 479.38K | 3.45M | 38.00K | 663.62K |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 0.00 | 21.10M | 6.97M | 0.00 |
| Repayment of Long-Term Debt | -34.92K | -22.96K | -87.68K | -263.13K |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | 0.00 | -26.20K | -165.86K | 0.00 |
| Net Cash From Financing Activities | -34.92K | 21.05M | 6.72M | -263.13K |
| Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Change in Cash & Cash Equivalents | -15.04M | 13.46M | 1.03M | -5.04M |
Portfolios with PTN
- Portfolio NameUser Type
- User2012 picks 10/28/20121
- ContributorBreakout Stocks Of The Week...
- UserJRC'S PICKS
- Uservlady 1
- Userjrc1947
- Usercny29
- UserFlytrapz Portfolio 1
- UserHardways_R1
- UserMDM
- Userpepe81 Portfolio 1
Latest PTN Headlines from TheStreet
- 5 Stocks Poised for Breakouts 10.26.12 | 01:10 pm
- Palatin Technologies' CEO Discusses F4Q12 Results - Earnings Call Transcript 09.11.12 | 02:09 pm
- Palatin Technologies' CEO Discusses F3Q2012 Results - Earnings Call Transcript 05.14.12 | 04:05 pm
- Palatin Technologies' CEO Discusses F2Q2012 Results - Earnings Call Transcript 02.15.12 | 02:02 pm
- Palatin Technologies CEO Discusses F1Q12 Results - Earnings Call Transcript 11.15.11 | 03:11 pm
- Palatin Technologies CEO Discusses F4Q2011 Results - Earnings Call Transcript 09.22.11 | 04:09 pm
- Palatin Technologies CEO Discusses F3Q2011 Results - Earnings Call Transcript 05.16.11 | 04:05 pm
- Palatin Technologies CEO Discusses Q4 2010 Results - Earnings Call Transcript 02.24.11 | 01:02 pm
- Palatin Technologies CEO Discusses F1Q2011 Results - Earnings Call Transcript 11.16.10 | 05:11 pm
- Globecomm Systems - Upgrades & Downgrades 09.30.10 | 11:09 am
Press Releases for PTN
- Palatin Technologies Announces Notification Of Patent Allowance On Melanocortin Receptor-Specific Peptides For Sexual Dysfunction - PR Newswire 05.02.13 | 07:05 am
- Palatin Technologies Announces Notification Of Patent Allowance On Melanocortin Receptor-1 Specific Peptides - PR Newswire 03.19.13 | 07:03 am
- Palatin Technologies To Present At The 25th Annual ROTH Conference - PR Newswire 03.15.13 | 07:03 am
- Palatin Technologies, Inc. To Present At The Cowen & Company 33rd Annual Health Care Conference - PR Newswire 03.04.13 | 07:03 am
- Palatin Technologies, Inc. To Present At 15th Annual BIO CEO & Investor Conference - PR Newswire 02.07.13 | 05:02 pm
- Palatin Technologies Receives $1.75 Million From Sale Of New Jersey State Tax Credits - PR Newswire 01.03.13 | 07:01 am
- Palatin Technologies, Inc. To Present At The 24th Annual Piper Jaffray Healthcare Conference - PR Newswire 11.20.12 | 05:11 pm
- Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference - PR Newswire 11.12.12 | 06:11 pm
- Palatin Technologies Reports Positive Results For Phase 2B Bremelanotide Female Sexual Dysfunction Trial - PR Newswire 11.08.12 | 07:11 am
- Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial - PR Newswire 09.10.12 | 07:09 am
Partner Headlines for PTN
- Pre-Market Earnings Report for September 11, 2012 : UNFI, AEPI, HSOL, PTN - NASDAQ 09.10.12 | 08:09 pm
- Benzinga's Microcap Movers for Friday July 6, 2012 - Benzinga 07.06.12 | 04:07 pm
- Setback for AZN Obesity Drug - Analyst Blog - Zacks 06.25.12 | 06:06 pm
- Palatin Technologies CEO Buys 50,000 Shares of PTN - Benzinga 03.03.11 | 04:03 pm
- Palatin Technologies, Inc. Announces Proposed Offering of Common Stock and Warrants - Benzinga 02.23.11 | 04:02 pm
- Palatin Announces Strategic Realignment of Operations - Benzinga 09.24.10 | 04:09 pm
